BYD Accelerates AssistedDriving Development as Competition Intensifies in Chinas EV Market
Teen GLP1 Purchases Raise Concerns Over App Store Accountability Frameworks
American Express National Bank Review 2026 NoFee HighYield Accounts and Expanded Online Banking Services
Flowers Foods Reaffirms FullYear Guidance Amid Input Cost Pressures
National Music Centre Appoints Steve Kane as Board Chair Announces Governance Updates
CPJ Calls for Press Freedom Benchmarks in Myanmars Political Transition
MPLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Gains 147
FGNXP Q1 2026 Earnings Massive EPS Surprise on OneTime Gains
WFRD Q1 2026 Earnings EPS Smashes Estimates But Stock Slips
Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations
Carriage Services Inc CSV Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue and Negative Stock Reaction
Crane Company CR Q1 2026 Earnings EPS Beat Drives Modest Stock Gains Amid Mixed Operating Trends
Pimco Municipal Income Fund II PML Holds Steady Amid Interest Rate Uncertainty
JetBlue Airways JBLU Rises 227 Airline Stock Approaches Resistance at 567
Afya Limited AFYA Faces Modest Decline Amid Consolidation Near Key Levels
Ardent Health ARDT Holds Near Support as Slight Gain Marks Cautious Session
Nuveen Quality Municipal Income Fund NAD Gains 095 as YieldSeeking Investors Return
Mercurys 52 Billion Valuation Marks 49 Surge Reinforcing Fintech Resilience
TBBB Q1 2026 Earnings Narrowly Misses Estimates Stock Flat
Netflix AdSupported Tier Reaches 250 Million Monthly Active Viewers Amid Sports Expansion
Aditxt Inc ADTX Q3 2025 Earnings Steep Loss Per Share as Stock Declines Sharply
AI Biotech Firm Secures 104 Million Investment from Nvidia
NOW Wallet Integrates Perpetual Futures and Prediction Markets New Features for Crypto Traders
Cement Makers Project 78 Growth in FY27 Amid West Asia Headwinds But Industry Growth Could Be Moderate at 555
PEW Q1 2026 Earnings EPS Beat Drives Optimism Despite Revenue Uncertainty and Stock Dip
Atossa Therapeutics ATOS Holds Steady Near 500 as Consolidation Continues